| 12364667 |
Anti-tumor platinum-based drug mineralized protein nanoparticle, preparation method therefor and use thereof |
Huabing Chen, Yibin DENG, Hong Yang, Hengte Ke, Ting Li +2 more |
2025-07-22 |
|
| 12280070 |
Drugs for prevention or treatment of sepsis |
Wei-Jan Huang, Haibo Qiu, Ke Fang, Jianfeng XIE, Yi Yan Yang +1 more |
2025-04-22 |
|
| 11938187 |
Methods and compositions for synthesis of two-photon cleavable phosphoramidite molecules for oligonucleotide conjugation |
Peggy Pik Kwan Lo, Dick Yan Tam |
2024-03-26 |
|
| 11919964 |
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof |
Gunasekaran Kannan, Edward John Belouski, Cen Xu |
2024-03-05 |
$184,315,000 |
| 11167039 |
MET antibody drug conjugates |
Yiqing Feng, Philip Arthur Hipskind, Renhua Li, Takako WILSON, Aaron D. Wrobleski |
2021-11-09 |
$1,948,455,000 |
| 10934362 |
Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof |
Gunasekaran Kannan, Edward John Belouski, Cen Xu |
2021-03-02 |
$464,158,000 |
| 10662189 |
PDE4 inhibitor |
Yunfu Luo, Chundao Yang, Maoyi LEI, Guoping HU, Jian Li +1 more |
2020-05-26 |
|
| 9670284 |
Therapeutic uses for VEGFR1 antibodies |
Zhonghua Qi, Matthew Douglas Breyer |
2017-06-06 |
$444,039,000 |
| 9580499 |
VEGFR2/Ang2 compounds |
Donmienne Doen Mun Leung, Jirong Lu, Ying Tang, Jianghuai Xu |
2017-02-28 |
$463,927,000 |
| 9328173 |
Multifunctional antibodies binding to EGFR and MET |
Hector Aldaz, Barrett Allan, Jirong Lu, Ying Tang, Sheng-Hung Tschang +1 more |
2016-05-03 |
$126,031,000 |
| 9260531 |
Anti-c-met antibodies |
Gregory Beuerlein, Julian Davies, Irene Jennifer Denning, Jirong Lu, Peter Edward Vaillancourt |
2016-02-16 |
$224,940,000 |
| 9201074 |
Anti-c-Met antibodies |
Julian Davies, Jirong Lu |
2015-12-01 |
$516,043,000 |
| 8398974 |
c-Met antibodies |
Julian Davies, Jirong Lu, Peter Edward Vaillancourt, Mark Andrew Wortinger, Wei Zeng |
2013-03-19 |
$250,036,000 |
| 8217148 |
c-Met antibodies |
Julian Davies, Jirong Lu, Peter Edward Vaillancourt, Mark Andrew Wortinger, Wei Zeng |
2012-07-10 |
$71,763,000 |
| 8182815 |
Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment |
Haijun Sun |
2012-05-22 |
|
| 8110191 |
Anti-IL-17 antibodies |
Barrett Allan, Chi-Kin Chow, Jirong Lu, Jonathan Wendell Tetreault, Ying Tang |
2012-02-07 |
$97,719,000 |
| 8043618 |
Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment |
Haijun Sun |
2011-10-25 |
|
| 7838638 |
Anti-IL-17 antibodies |
Barrett Allan, Chi-Kin Chow, Jirong Lu, Jonathan Wendell Tetreault |
2010-11-23 |
$79,286,000 |
| 7101539 |
Use of LP82 to treat hematopoietic disorders |
Josef Heuer, Timothy W. Noblitt |
2006-09-05 |
$72,797,000 |
